Low-dose acyclovir for prophylaxis of varicella-zoster virus reactivation after hematopoietic stem cell transplantation in children.

Yasuhisa TatebeSoichiro UshioSatoru EsumiHikaru SadaMotoharu OchiKosuke TamefusaHisashi IshidaKaori FujiwaraKiichiro KanamitsuKana WashioRisa KatsubeKiminaka MurakawaYoshito Zamami

Published in: Pediatric blood & cancer (2022)

Low-dose acyclovir (15 mg/kg/day) could be effective for preventing VZV reactivation after HSCT in children because VZV reactivation seldom occurs during the administration of 15 mg/kg/day acyclovir.

Keyphrases

low dose
herpes simplex virus
young adults
high dose
acute myeloid leukemia